Trial Profile
Phase II Trial of Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage: BLOcking the Cytokine IL-1 in ICH
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Feb 2022
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Cerebral haemorrhage
- Focus Therapeutic Use
- Acronyms BLOC-ICH
- 04 Oct 2021 Status changed from active, no longer recruiting to completed.
- 03 Mar 2021 Status changed from recruiting to active, no longer recruiting.
- 03 Oct 2020 Planned End Date changed from 29 May 2020 to 1 May 2021.